Millions of Americans enrolled in Medicare Part B can receive a yearly wellness visit and most cancer screenings without paying a copay or meeting a deductible, yet a significant share of eligible beneficiaries never schedule these appointments. The Centers for Medicare and Medicaid Services lists the Annual Wellness Visit with both copayment and deductible waived, and the same zero-cost-sharing structure applies to screening mammograms, colonoscopies, and low-dose CT lung scans when clinical criteria are met. The gap between what is covered and what is actually used raises a direct question: whether pairing digital outreach tools with existing telehealth billing pathways could close that gap, especially for beneficiaries in rural areas who face longer travel times and fewer primary care options.
Why the zero-cost wellness benefit matters right now
The Annual Wellness Visit is not a standard physical exam. It produces a personalized prevention plan and a health-risk assessment tailored to each beneficiary’s age, medical history, and lifestyle factors. That plan is supposed to serve as the starting point for ordering the cancer screenings and other preventive services Medicare already covers at no charge. When the visit does not happen, the downstream screening referrals often do not happen either.
Rural beneficiaries face a compounding problem. Fewer primary care clinicians per capita means longer wait times and greater travel distances, both of which discourage scheduling a visit that many people assume will cost them money. A targeted hypothesis worth testing is that linking wellness-visit reminders directly to Medicare telehealth billing codes could raise completed Annual Wellness Visit rates among rural enrollees more effectively than traditional mail or phone outreach alone. Telehealth removes the travel barrier, and embedding the reminder inside an existing billing workflow reduces the administrative friction that keeps many practices from proactively reaching out.
The financial design of the benefit supports this approach. The CMS preventive services chart confirms that copayment, coinsurance, and deductible are all waived for the Annual Wellness Visit. The Medicare program’s own description of yearly wellness visits states that beneficiaries with Part B can get this visit once a year at no cost when they see a participating provider. If the price is zero, the remaining barriers are awareness and access, both of which telehealth-linked outreach can address by meeting people where they are and clarifying that the visit itself should not generate a bill.
What Medicare actually covers at zero cost, and where charges appear
The zero-dollar promise holds across several cancer screenings, but each one carries specific conditions that determine whether cost-sharing kicks in. Screening mammograms are covered under Part B for eligible beneficiaries with no copay or deductible. Diagnostic mammograms, ordered after a suspicious finding, shift to standard Part B cost-sharing: typically 20% coinsurance after the deductible, according to the Medicare mammogram coverage information. That distinction matters because a beneficiary who goes in expecting a free screening can face an unexpected bill if the radiologist converts the visit to a diagnostic study.
Colonoscopy coverage follows a similar pattern with one well-documented exception. When a colonoscopy is performed strictly as a screening test, the beneficiary owes no copay or deductible. But if a polyp or other tissue is found and removed during the procedure, the claim is processed differently. In that scenario, the beneficiary pays 15% coinsurance for both provider and facility charges, while the Part B deductible does not apply. That 15% figure can translate into hundreds of dollars depending on the setting, and many patients learn about it only after the fact, when an explanation of benefits arrives in the mail.
Low-dose CT lung cancer screening rounds out the major cancer benefits tied to the wellness visit. The National Coverage Determination for LDCT lung screening explicitly states that Part B coinsurance and deductible are waived when clinical eligibility criteria are met, such as age range and smoking history. As with mammography and colonoscopy, the promise of no out-of-pocket cost applies only when the service is coded and billed as a qualifying screening. Once a test is reclassified as diagnostic-because of a symptom, a prior abnormal result, or a follow-up need-standard cost-sharing rules resume.
One additional wrinkle applies to the wellness visit itself. Costs can appear during the appointment if the clinician performs additional tests or services that fall outside the defined preventive benefit. A blood draw ordered to investigate a new symptom, for example, can trigger standard Part B cost-sharing even though the wellness visit portion remains free. The CMS quick-reference chart, available as a text-only PDF, spells out service-by-service cost-sharing columns that clinicians and billing staff use to determine what is and is not waived. For beneficiaries, that nuance is rarely visible, which fuels confusion when a “free” visit leads to a separate bill.
Gaps in data and the next question for rural beneficiaries
The strongest evidence available confirms what is covered and at what price. What it does not reveal is how many beneficiaries actually complete these visits and screenings each year, broken down by geography or demographics. CMS publishes claims-level utilization data, but publicly available breakdowns by rural versus urban status, race, or income remain limited in the reporting reviewed here. Without that granularity, it is difficult to measure whether any specific outreach method, including telehealth-linked reminders, is producing measurable gains for the populations that face the highest barriers.
This lack of detail is especially important for rural communities. Travel distance, weather, transportation access, and workforce shortages all interact to suppress in-person preventive care. If the only metric available is a national average utilization rate, localized disparities can remain hidden. A county where only a small minority of eligible residents receive an Annual Wellness Visit may look indistinguishable from a neighboring area with much higher uptake when data are aggregated at the state or regional level.
To answer the next set of questions, researchers and policymakers would need more finely grained measures. At a minimum, that would include Annual Wellness Visit completion rates and key screening rates stratified by rurality, age, sex, and dual-eligibility status. With those metrics in hand, a randomized or quasi-experimental test of telehealth-integrated outreach could compare outcomes between practices that embed digital reminders into their workflows and those that rely on traditional methods. Claims data could then show whether more rural beneficiaries not only schedule wellness visits but also follow through on mammograms, colonoscopies, and lung scans ordered as a result.
For clinicians and health systems, the policy framework is already in place. The benefit design documented in the CMS preventive services chart means that practices can confidently tell Part B patients that the wellness visit itself should not generate out-of-pocket costs. The challenge is operational: configuring patient portals, automated messaging systems, and telehealth platforms so that outreach is timely, understandable, and tied to clear instructions about how to schedule either a virtual or in-person appointment.
For beneficiaries, clearer communication about both the zero-cost elements and the potential triggers for cost-sharing could reduce surprise bills that undermine trust. Explaining, in plain language, that a wellness visit and qualifying screenings are free, while diagnostic follow-up or additional testing may carry charges, can help set realistic expectations. Paired with telehealth options that reduce travel burdens, that transparency may make it more likely that rural residents will take advantage of the preventive care they are already entitled to receive.
